Skip to main content
main-content
Top

05-05-2017 | Brigatinib | Article

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

Kim D-W et al. J Clin Oncol 2017; 35(22): 2490-2498. doi:10.1200/JCO.2016.71.5904

Please log in to get access to this content

Related topics